The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prevalence and characteristics of patients with stage IV solid tumors who receive no anticancer therapy.
Alexander C. Small
No relevant relationships to disclose
Che-Kai Tsao
No relevant relationships to disclose
Erin L. Moshier
No relevant relationships to disclose
Benjamin Adam Gartrell
No relevant relationships to disclose
Juan P. Wisnivesky
No relevant relationships to disclose
James H. Godbold
No relevant relationships to disclose
Cardinale B. Smith
No relevant relationships to disclose
Guru Sonpavde
No relevant relationships to disclose
William K. Oh
No relevant relationships to disclose
Matt D. Galsky
No relevant relationships to disclose